Douglas T Ross

Summary

Publications

  1. pmc Microarrays and molecular markers for tumor classification
    Brian Z Ring
    Applied Genomics Inc, 525 Del Rey Ave B, Sunnyvale, CA 94085, USA
    Genome Biol 3:comment2005. 2002
  2. pmc Basal cytokeratins and their relationship to the cellular origin and functional classification of breast cancer
    Barry A Gusterson
    Division of Cancer Sciences and Molecular Pathology, Western Infirmary, University of Glasgow, Glasgow, UK
    Breast Cancer Res 7:143-8. 2005
  3. pmc TLE3 as a candidate biomarker of response to taxane therapy
    Swati A Kulkarni
    Department of Surgical Oncology, Roswell Park Cancer Institute, Buffalo, NY 14263, USA
    Breast Cancer Res 11:R17. 2009
  4. pmc Chemosensitivity and stratification by a five monoclonal antibody immunohistochemistry test in the NSABP B14 and B20 trials
    Douglas T Ross
    Applied Genomics, Inc, Burlingame, California 94010, USA
    Clin Cancer Res 14:6602-9. 2008
  5. doi request reprint A novel five-antibody immunohistochemical test for subclassification of lung carcinoma
    Brian Z Ring
    Department of Research and Development, Applied Genomics Inc, Burlingame, CA 94010, USA
    Mod Pathol 22:1032-43. 2009
  6. ncbi request reprint Novel prognostic immunohistochemical biomarker panel for estrogen receptor-positive breast cancer
    Brian Z Ring
    Applied Genomics Inc, 863 Mitten Rd 103, Burlingame, CA, USA
    J Clin Oncol 24:3039-47. 2006
  7. pmc Gene expression patterns within cell lines are predictive of chemosensitivity
    Brian Z Ring
    Applied Genomics Inc, Burlingame, CA, 94010, USA
    BMC Genomics 9:74. 2008
  8. pmc Predicting the sites of metastases
    Brian Z Ring
    Applied Genomics Inc, 525 Del Rey Avenue, Sunnyvale, CA 94085, USA
    Genome Biol 6:241. 2005

Collaborators

Detail Information

Publications8

  1. pmc Microarrays and molecular markers for tumor classification
    Brian Z Ring
    Applied Genomics Inc, 525 Del Rey Ave B, Sunnyvale, CA 94085, USA
    Genome Biol 3:comment2005. 2002
    ..Unfortunately, at present, differences between studies of similar tumor types can be as striking as their similarities...
  2. pmc Basal cytokeratins and their relationship to the cellular origin and functional classification of breast cancer
    Barry A Gusterson
    Division of Cancer Sciences and Molecular Pathology, Western Infirmary, University of Glasgow, Glasgow, UK
    Breast Cancer Res 7:143-8. 2005
    ..This article reviews the lineages in the normal breast in relation to what have become known as the 'basal-like' carcinomas...
  3. pmc TLE3 as a candidate biomarker of response to taxane therapy
    Swati A Kulkarni
    Department of Surgical Oncology, Roswell Park Cancer Institute, Buffalo, NY 14263, USA
    Breast Cancer Res 11:R17. 2009
    ..The addition of taxanes (Ts) to chemotherapeutic regimens has not demonstrated a consistent benefit in early-stage breast cancer. To date, no clinically relevant biomarkers that predict T response have been identified...
  4. pmc Chemosensitivity and stratification by a five monoclonal antibody immunohistochemistry test in the NSABP B14 and B20 trials
    Douglas T Ross
    Applied Genomics, Inc, Burlingame, California 94010, USA
    Clin Cancer Res 14:6602-9. 2008
    ....
  5. doi request reprint A novel five-antibody immunohistochemical test for subclassification of lung carcinoma
    Brian Z Ring
    Department of Research and Development, Applied Genomics Inc, Burlingame, CA 94010, USA
    Mod Pathol 22:1032-43. 2009
    ..The results also suggest that if validated in prospectively defined clinical trials this classifier might identify candidates for targeted therapy that are overlooked with current diagnostic approaches...
  6. ncbi request reprint Novel prognostic immunohistochemical biomarker panel for estrogen receptor-positive breast cancer
    Brian Z Ring
    Applied Genomics Inc, 863 Mitten Rd 103, Burlingame, CA, USA
    J Clin Oncol 24:3039-47. 2006
    ..We have used gene expression data to guide the production of hundreds of novel antibody reagents to discover novel diagnostic tools for stratifying carcinoma patients...
  7. pmc Gene expression patterns within cell lines are predictive of chemosensitivity
    Brian Z Ring
    Applied Genomics Inc, Burlingame, CA, 94010, USA
    BMC Genomics 9:74. 2008
    ..A strong correlation between the pattern of expression of a biomarker and sensitivity to a compound could suggest a clinically interesting biological relationship between the two...
  8. pmc Predicting the sites of metastases
    Brian Z Ring
    Applied Genomics Inc, 525 Del Rey Avenue, Sunnyvale, CA 94085, USA
    Genome Biol 6:241. 2005
    ..Such signatures of site-specific metastatic capabilities might allow the targeting of therapy to likely sites of metastasis...